NanoViricides, Inc. a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced that Anil R. Diwan, PhD, President and Executive Chairman of the Company, will participate in the “B. Riley FBR Virtual Infectious Disease Summit - Therapeutics Day” on Tuesday, July 21, 2020.
July 21, 2020
· 8 min read